Alphabet Inc (NASDAQ:GOOG) shares surged to a fresh all-time high of $256.17 on Thursday morning, driven by the tech giant’s continued innovation across artificial intelligence, cloud computing, and digital advertising.
Thursday’s rally comes after Google unveiled a new 27-billion-parameter model for single-cell biology, C2S-Scale 27B, based on its Gemma platform.
The model predicted a previously unknown cancer-cell behavior, which was subsequently validated in living cells.
Tests indicated that combining a CK2 inhibitor, silmitasertib, with low-dose interferon increased antigen presentation by roughly 50%, effectively turning “cold” tumors “hot.” If further laboratory and clinical studies confirm these results, the finding could open new avenues for cancer therapies.
In addition to healthcare-related research, Google is making major investments in artificial intelligence and data center infrastructure. The company plans to invest $15 billion over five years to build its first AI hub in Andhra Pradesh, India, featuring gigawatt-scale data center operations and an expanded fiber-optic network.
In the US, Google will invest $9 billion in South Carolina, expanding AI infrastructure at its Berkeley County data center campus and new sites in Dorchester County.